In case of other HPC (BRCA2, BRCA1, PALB2, ATM, MLH1, MSH2, or MSH6) and familial PC, screening should be introduced in patients with the history of at least one first-degree relative with diagnosed PC. This evidence concerns the gene MSH2 and pachyonychia congenita.